Common name

IUPAC name

3-[(2R,3R)-1-(dimethylamino)-2-methylpentan-3-yl]phenol

SMILES

CC[C@H]([C@@H](C)CN(C)C)C1=CC(O)=CC=C1

Compound class

Analgesics; Nervous System; Opioids; Cytochrome P-450 CYP2C9 Inhibitors; Cytochrome P-450 CYP2C9 Inducers; Cytochrome P-450 CYP2C19 Inducers; CYP2D6 Inducers; CYP2D6 Inducers (strong);

Therapeutic area

The immediate-release formulation of tapentadol is indicated for the relief of moderate to severe acute pain. The long-acting formulation serves as a continuous, around-the-clock analgesic that is indicated for the relief of moderate to severe chronic pain or neuropathic pain associated with diabetic peripheral neuropathy.